Increasing application of HLA typing in disease diagnosis, increasing number of organ transplantation procedures performed globally, and rising prevalence of chronic diseases are key factors driving market growth
The global HLA typing for transplant market size is expected to reach USD 1,206.02 Million by 2028 at a CAGR of 7.0%, according to the latest report by Reports and Data. Increasing prevalence of infectious diseases, rising number of transplant procedures, and growing investment in Human Leukocyte Antigen research are key factors expected to drive market revenue growth over the forecast period. In addition, increasing need for organ transplants due to rising incidence of organ failure due to unhealthy lifestyle and eating habits, and excessive alcohol consumption and drug abuse are other key factors driving revenue growth of the market.
Human Leukocyte Antigen (HLA) typing is primarily carried out to assess immune compatibility of donors and recipient for bone marrow or cord blood transplants. HLA molecules are major molecules that initiate graft rejection and have been widely studied in transplantation biology. HLA typing and matching offers numerous benefits in organ transplantation such as better graft function, longer graft survival, reduced chances of graft rejection, and increased possibility of reduced immunosuppression. Technological advancement in molecular diagnostics have enabled HLA typing to offer more accurate results based on the identification of differences in HLA genes. This is expected to drive revenue growth of the market over the forecast period.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3976
The rapid adoption of AI, ML, and IoT and robust data management processes has made the hospitals and clinical settings smarter. New technologies and solutions have improved the normal medical processes such as clinical diagnosis, treatment, diseases management, and monitoring patient recovery after discharge. Rapid digitalization and increasing adoption of virtual care and telemedicine is further expected to positively impact the revenue growth of the market going ahead.
Emergence of new healthcare and telemedicine startups, increasing number of collaborations among healthcare facilities and research institutions, and rising focus on patient engagement solutions has further fueled revenue growth of the market. Key companies are forming strategic alliances and collaborative ventures such as mergers and acquisitions, joint ventures, partnerships, manufacturing and licensing agreements, and product launches among others.
Order this report @ https://www.reportsanddata.com/report-pricing/3976
Leading Players Analyzed in the Report:
Thermo Fisher Scientific, Inc., QIAGEN N.V., Illumina, Inc., CareDx, Inc., Immucor, Inc., Bio-Rad Laboratories, Inc., F. Hoffman-La Roche Ltd., Hologic, Inc., Luminex, Biofortuna, Takara Bio, and Omixon, among others.
Furthermore, to offer a better understanding of the competitive landscape, an extensive SWOT analysis and Porter’s Five Forces analysis are included in the report. Along with this, feasibility analysis and investment return analysis are also covered in the report.
The report further discusses in detail the regional spread of the global HLA Typing for Transplant market along with analysis of production and consumption patterns, import/export analysis, supply and demand ratio, market share and size based on volume and value, trends and demands, revenue share, and presence of the key players of the market.
Key Regions Studied in the Report:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, France, Rest of Europe)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Segmentation based on Types:
Technology Outlook (Revenue, USD Million; 2018-2028)
- Molecular Assay Technologies
- PCR-Based Molecular Assays
- Real-time PCR
- Sequence-specific Primer-PCR
- Sequence-specific Oligonucleotide-PCR
- Other PCR-based Molecular Assays
- Sequencing-based Molecular Assays
- Sanger Sequencing
- Next-generation Sequencing
- Other Sequencing-based Molecular Assays
- Non-molecular Assay Technologies
Product Outlook (Revenue, USD Million; 2018-2028)
- Instrument
- Reagents
- Services
Application Outlook (Revenue, USD Million; 2018-2028)
- Diagnostic Applications
- Antibody Screening
- Chimerism Monitoring
- Others
- Research Applications
End-use Outlook (Revenue, USD Million; 2018-2028)
- Hospitals
- Diagnostic Labs
- Academic & Research Institutes
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3976
Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.
Browse More Reports;
Vision Screeners Market @ https://www.biospace.com/article/vision-screeners-market-trends-size-segment-and-industry-growth-by-forecast-to-2028/
Urinary Stone Treatment Device Market @ https://www.biospace.com/article/urinary-stone-treatment-device-market-trends-revenue-key-players-growth-share-and-forecast-till-2028/
Interventional Oncology Market @ https://www.biospace.com/article/interventional-oncology-market-analysis-development-opportunities-future-growth-and-business-prospects-by-forecast-to-2028/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
